Nurses Revision

Emergency Medicine & Critical Care

Hypoglycaemia Management

A clinical condition characterized by abnormally low blood glucose levels (typically <3.0 mmol/L or <55 mg/dl), leading to neuroglycopenic and autonomic symptoms. Requires prompt recognition and treatment to prevent neurological damage.

Also known as: Low Blood Sugar

View images for Hypoglycaemia Management (Google Images, opens in a new tab)
On this page

Referral and warning signs

When to refer

Refer to HC4/Hospital if: Patient remains unconscious or confused despite glucose administration. Hypoglycaemia is severe or recurrent without obvious cause. Caused by long-acting insulin or oral hypoglycaemic agents (requires prolonged observation/admission). Suspected underlying cause requires hospital investigation (e.g., insulinoma, adrenal insufficiency).

Red flags

  • Unconsciousness or coma
  • Active seizures
  • Persistent confusion or neurological deficit despite glucose correction
  • Hypoglycaemia caused by long-acting insulin or sulphonylurea agent
  • Recurrent episodes without clear explanation
  • Inability to maintain safe glucose levels orally

Signs and symptoms

  • Autonomic symptoms (early): Sweating (diaphoresis), Tremors, Palpitations, Anxiety, Nervousness, Hunger
  • Neuroglycopenic symptoms (later/severe): Dizziness, Confusion, Difficulty concentrating, Weakness, Drowsiness, Behavioural changes, Blurred vision, Slurred speech, Headache, Seizures, Loss of consciousness (coma)

Risk factors

  • Diabetes mellitus treatment (Insulin overdose, excessive dose of sulphonylureas, missed meals, excessive exercise)
  • Severe Sepsis or critical illness
  • Malaria (especially severe malaria, or due to quinine treatment)
  • Severe malnutrition / Starvation
  • Hepatic disease (liver failure)
  • Renal failure
  • Excessive alcohol intake (especially without food)
  • Adrenal insufficiency (cortisol deficiency)
  • Growth hormone deficiency
  • Insulinoma (rare pancreatic tumour)
  • Prematurity (infants)
  • Post-gastrectomy (dumping syndrome)

Diagnosis

Clinical assessment

Suspicion based on presence of symptoms (autonomic or neuroglycopenic) in a patient with risk factors. Confirmation requires blood glucose measurement.

Investigations

  • Point-of-care blood glucose measurement (fingerstick test). Confirmed if <3.0 mmol/L (55 mg/dl) with symptoms.
  • Laboratory plasma glucose (more accurate).
  • Further investigations to determine underlying cause if not obvious (e.g., investigations for sepsis, malaria test, liver function tests, cortisol level, insulin/C-peptide levels - usually hospital level).

Diagnostic criteria

Whipple's Triad is classically used: 1. Symptoms consistent with hypoglycaemia. 2. Low plasma glucose concentration measured at the time of symptoms. 3. Relief of symptoms after the glucose level is raised.

Management

Non-pharmacological management

  • If patient is conscious, alert, and able to swallow safely:
  • Give fast-acting oral carbohydrate: 15-20g of glucose (e.g., 3-4 glucose tablets, 1/2 cup fruit juice or sugary non-diet soda, 3 teaspoons or packets of sugar dissolved in water).
  • Recheck blood glucose after 15 minutes.
  • If still low, repeat oral glucose.
  • Once glucose is >4.0 mmol/L, provide a snack containing complex carbohydrates and protein (e.g., bread, crackers with cheese, milk) to prevent recurrence, especially if next meal is >1 hour away or if caused by long-acting insulin/oral agent.

Pharmacological treatment

  • If patient is unconscious, having seizures, or unable to swallow safely:
  • Secure airway, breathing, circulation (ABC).
  • Establish IV access.
  • Adults: Give Glucose 50% 20-50 ml IV slowly (over 1-3 minutes). Flush line afterwards. Follow with Dextrose 10% IV infusion if needed until patient is fully conscious and able to eat.
  • Children: Give Dextrose 10% IV 2-5 ml/kg bolus slowly. Follow with Dextrose 10% infusion if needed.
  • If IV access cannot be obtained quickly: Glucagon 1 mg IM/SC (Adults/Children >25kg); 0.5mg (Children <25kg). Note: Glucagon may be ineffective in starvation, alcohol-induced hypoglycaemia, or adrenal insufficiency.
  • Treat underlying cause (e.g., adjust diabetes medication, treat sepsis/malaria).
  • Follow specific Ugandan treatment algorithms/guidelines.

Monitoring

Monitor blood glucose frequently (e.g., every 15-30 minutes initially, then hourly) until stable and patient is conscious and eating. Continue monitoring for several hours, especially if caused by long-acting insulin or oral hypoglycaemic agents (e.g., sulphonylureas - risk of recurrence is high, may require admission and prolonged infusion). Monitor neurological status.

Complications

  • Seizures
  • Permanent neurological damage (brain damage) if severe or prolonged
  • Coma
  • Cardiac arrhythmias
  • Injury from falls or accidents during episode
  • Death

Prevention

  • Patient education (especially for diabetics) on recognizing early symptoms and self-treatment.
  • Regular meals and snacks for those at risk (diabetics, post-gastrectomy).
  • Appropriate dosing and timing of insulin and oral hypoglycaemic agents.
  • Regular blood glucose monitoring for diabetics.
  • Advise patients at risk to carry fast-acting glucose (tablets, gel, sugar packets) at all times.
  • Advise diabetic patients to wear medical identification (bracelet/tag).

Patient education

  • Teach patients (especially diabetics) and their families about symptoms of hypoglycaemia.
  • Explain how to treat mild-moderate episodes with oral glucose.
  • Explain when to seek emergency help.
  • Discuss prevention strategies (meal timing, medication adherence, glucose monitoring).
  • Importance of carrying fast-acting glucose and medical ID.
  • How to use glucagon kit if prescribed.

Uganda-specific notes

Note preparation instructions for Dextrose 10% (from D5% and D50%). Always consider severe malaria and sepsis as potential causes of hypoglycaemia, especially in febrile patients with altered mental status. Quinine therapy for malaria can also induce hypoglycaemia.

References

  • Uganda Clinical Guidelines (UCG) 2023

    Chapter 1, Section 1.1.6

For learning and professional reference. Use current local guidance and clinical judgement.

Browse all conditions

Want notes in PDF? Join our classes!!

Send us a message on WhatsApp
0726113908

Scroll to Top
Enable Notifications OK No thanks